Vaccines (Mar 2024)

Anti-SARS-CoV-2 Vaccination and PIMS-TS—Friends or Foe? Case Reports and Literature Review

  • Violetta Opoka-Winiarska,
  • Izabela Morawska-Michalska,
  • Paulina Mertowska,
  • Krzysztof Gosik,
  • Olga Kądziołka,
  • Ewelina Grywalska

DOI
https://doi.org/10.3390/vaccines12030278
Journal volume & issue
Vol. 12, no. 3
p. 278

Abstract

Read online

Pediatric inflammatory, multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS), also known as a multisystem inflammatory syndrome in children (MIS-C), is diagnosed in children who develop an inadequate inflammatory response after exposure to the SARS-CoV-2 virus. The pathogenesis of the abnormal response of the immune system to a previous SARS-COV-2 infection has not been explained. Similarly, the safety and effectiveness of COVID-19 vaccinations in this group of patients have become the subject of clinical discussion. Presenting experiences from many centers aims to answer this question. We present 4 cases of patients who suffered from PIMS-TS. Three of them were safely vaccinated against COVID-19 after illness. One patient developed PIMS-TS temporarily associated with COVID-19 vaccination. We also collected and discussed data from other centers.

Keywords